165 related articles for article (PubMed ID: 11197083)
1. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
2. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
Griffin BW; Klimko P; Crider JY; Sharif NA
J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
[TBL] [Abstract][Full Text] [Related]
3. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
4. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
5. FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study.
Griffin BW; Williams GW; Crider JY; Sharif NA
J Pharmacol Exp Ther; 1997 May; 281(2):845-54. PubMed ID: 9152393
[TBL] [Abstract][Full Text] [Related]
6. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.
Sharif NA; Davis TL; Williams GW
J Pharm Pharmacol; 1999 Jun; 51(6):685-94. PubMed ID: 10454045
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
Ansari HR; Kaddour-Djebbar I; Abdel-Latif AA
Exp Eye Res; 2004 Feb; 78(2):285-96. PubMed ID: 14729360
[TBL] [Abstract][Full Text] [Related]
9. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
11. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
Crider JY; Griffin BW; Sharif NA
Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
14. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.
Sharif NA; Klimko PG
Br J Pharmacol; 2019 Apr; 176(8):1059-1078. PubMed ID: 29679483
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha.
Kunapuli P; Lawson JA; Rokach J; FitzGerald GA
J Biol Chem; 1997 Oct; 272(43):27147-54. PubMed ID: 9341156
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization.
Griffin BW; Magnino PE; Pang IH; Sharif NA
J Pharmacol Exp Ther; 1998 Jul; 286(1):411-8. PubMed ID: 9655886
[TBL] [Abstract][Full Text] [Related]
18. Bimatoprost and its free acid are prostaglandin FP receptor agonists.
Sharif NA; Williams GW; Kelly CR
Eur J Pharmacol; 2001 Dec; 432(2-3):211-3. PubMed ID: 11740958
[TBL] [Abstract][Full Text] [Related]
19. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.
Thieme H; Schimmat C; Münzer G; Boxberger M; Fromm M; Pfeiffer N; Rosenthal R
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):938-45. PubMed ID: 16505027
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
